AAAMS

JUNE 20, 2024

This guide discusses how to network in the medical field and advance your career. Common networking opportunities include: Alumni networks: Medical students and graduates can often access an alumni network to connect with fellow students in the medical field.

Networking 52

Networking Medical Social Media Continuous Education 52

AAAMS

JUNE 20, 2024

This guide discusses how to network in the medical field and advance your career. Common networking opportunities include: Alumni networks: Medical students and graduates can often access an alumni network to connect with fellow students in the medical field.

Networking 52

Networking Medical Social Media Continuous Education 52

The Dermatology Digest

MARCH 18, 2024

If approved, we believe that DFD-29 will be the only oral medication to address both inflammatory lesions and erythema from rosacea, and will be a preferred treatment option by physicians and their patients to address the condition.”

Rosacea 74

Rosacea Medical Office Clinic 74

The Dermatology Digest

APRIL 12, 2024

Recent cases where possibly counterfeit neurotoxins in Illinois and Tennessee led to a cluster of illnesses resembling Botulism highlight the need to strengthen patient safety through increased oversight of medical care in all settings, according to the American Society for Dermatologic Surgery Association (ASDSA).

Safety 69

Safety Surgery Medical Training 69

The Dermatology Digest

FEBRUARY 14, 2024

“We are thankful to the patients and medical experts whose insights informed our clinical trials, which assessed nemolizumab’s ability to reduce the symptoms of itch and skin lesions. In the ARCADIA program, nemolizumab clinically improved skin lesions and rapidly improved itch and sleep disturbance.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

AUGUST 13, 2024

More data will be needed to define the safety profile of JAK inhibitors in Down syndrome, and we look forward to the completion of the trial and analysis of the full dataset.”

Clinic 74

Clinic Safety Dermatitis Medical 74

The Dermatology Digest

FEBRUARY 11, 2024

A meta-analysis of 45 randomized clinical trials comprised of 12,996 patients disclosed neither an increased risk of major cardiovascular events (MACE) such as heart attack and stroke) nor of venous thromboembolic events (VTE). This particular study did not address other safety concerns, such as all-cause mortality, infections, or cancer.

Dermatology 74

Dermatology Safety Clinic Therapy 74

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

First Derm

FEBRUARY 21, 2024

Social media significantly influences the popularity of retinol among young people, leading to increased experimentation without considering safety. There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision.

Retinol 80

Retinol Social Media Skincare Routine Skincare 80

The Dermatology Digest

APRIL 7, 2024

The new ladder divides nonsteroidal medication classes into treatments for exacerbations and maintenance therapies in an escalating order based on their increasing potential for adverse effects. Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A.

Treatments 77

Treatments Dermatitis Therapy Medical 77

West Lake Dermatology

SEPTEMBER 24, 2024

In the ever-evolving world of weight loss treatments, GLP-1 agonists like semaglutide (the active ingredient in popular medications like Ozempic or Wegovy) and tirzepatide (the active ingredient in Mounjaro) have rapidly gained popularity. of their body weight over 68 weeks, compared to just 2.4% in the placebo group.

Medical 36

Medical Diet Safety Sustainability 36

The Dermatology Digest

DECEMBER 13, 2024

This approval is based on positive results from the phase III ARCADIA clinical trial program which evaluated the efficacy and safety of nemolizumab in combination with background TCS, with or without TCI, versus placebo in combination with TCS, with or without TCI, in 1,728 patients aged 12 or older with moderate to severe atopic dermatitis.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

The Dermatology Digest

JULY 24, 2024

We will prioritize quality, broaden choices for medical professionals, and provide superior experiences and accessibility to the consumers.” This BLA/MAA for BAT2206 is based on the totality of evidence comprising a comprehensive analytical, non-clinical and clinical data package.

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

JANUARY 5, 2024

Journey Medical Corporation has submitted a New Drug Application (NDA) to the U.S. The NDA submission is based on positive data from Journey Medical’s two DFD-29 Phase 3 clinical trials for the treatment of rosacea. DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd.

Rosacea 36

Rosacea Medical Office Clinic 36

Academic Alliance in Dermatology

FEBRUARY 13, 2024

This is where medical-grade skincare like SkinCeuticals, ZO, Colorescience, Obagi, SkinMedica and Alastin distinctly outshine drugstore brands. Let’s explore why medical-grade skincare is the superior choice for anyone serious about their skin health. This means they can penetrate deeper into the skin, targeting concerns at their root.

Medical Grade Skincare 36

Medical Grade Skincare Medical Skincare Skin Health 36

Academic Alliance in Dermatology

FEBRUARY 13, 2024

This is where medical-grade skincare like SkinCeuticals, ZO, Colorescience, Obagi, SkinMedica and Alastin distinctly outshine drugstore brands. Let’s explore why medical-grade skincare is the superior choice for anyone serious about their skin health. This means they can penetrate deeper into the skin, targeting concerns at their root.

Medical Grade Skincare 36

Medical Grade Skincare Medical Skincare Skin Health 36

The Dermatology Digest

SEPTEMBER 20, 2024

Food and Drug Administration (FDA) has approved Alpha Tau Medical Ltd.’s The clinical study, which is an investigator-initiated study led by the Winship Cancer Institute of Emory University in Atlanta, GA, has been approved to enroll up to 28 U.S. patients at up to eight institutions in the U.S., Dr. Robert B.

Office 74

Office Clinic Safety Medical 74

The Dermatology Digest

MARCH 5, 2024

Hugel plans to accelerate its transition for approved medical use with the goal of launching to aesthetic clinicians in the second half of 2024. .: Botox Cosmetic (Allergan), Dysport (Galderma), Jeuveau (Evolus), Xeomin (Merz Aesthetic), Daxxify (Revance), and Letybo (Hugel). and Europe.

Branding 74

Branding Injections Safety Facials 74

The Dermatology Digest

JANUARY 29, 2024

The STudy of Roflumilast foam Applied Topically for the redUction of seborrheic derMatitis (STRATUM) was a parallel group, double-blind, vehicle-controlled study evaluating the safety and efficacy of Zoryve (roflumilast) foam, 0.3% Zoryve foam was well-tolerated with a favorable safety and tolerability profile.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

JANUARY 20, 2024

The study is designed to assess the safety, tolerability, and pharmacokinetics, of orally administered EVO756. Evommune’s pre-clinical data demonstrates that by blocking activation of MRGPRX2 and degranulation of mast cells, EVO756 has the potential to be a first-in-class oral treatment for a variety of mast cell-mediated diseases.

Safety 74

Safety Office Dermatitis Clinic 74

The Dermatology Digest

SEPTEMBER 23, 2024

These trials evaluated the safety and efficacy of delgocitinib compared to cream vehicle. This news is testament to our dedication to making a fundamental difference for those who need us most in medical dermatology. Both trials met their primary and all secondary endpoints. with the same determination and dedication.” The post E.C.

Eczema 66

Eczema Safety Dermatology Clinic 66

Alison Bladh

JANUARY 16, 2025

Clinical studies indicate that saw palmetto can be an effective option for managing urinary symptoms during perimenopause and menopause, improving quality of life for many women. It may also interact with anticoagulant medications, so be sure to consult with a healthcare professional before starting supplementation.

Extractions 98

Extractions Management Consultation Consultations 98

The Dermatology Digest

JULY 29, 2024

is initiating the Onward Phase 3 Clinical Program evaluating ESK-001, an oral tyrosine kinase 2 (TYK2) inhibitor, in moderate-to-severe plaque psoriasis. Key secondary endpoints will include PASI 90, PASI 100 and sPGA 0 measured at Weeks 16 and 24, and safety and tolerability. Alumis Inc.

Clinic 36

Clinic Safety Office Treatments 36

The Dermatology Digest

MARCH 5, 2024

Additionally, more than 85% of clinical trial subjects were satisfied with how balanced, well-proportioned, and symmetric their face looked three months after treatment. The Allergan Medical Institute (AMI) team can train aesthetic providers on safe and effective treatments using the Allergan Aesthetics portfolio to address 90% of the face.

Portfolios 74

Portfolios Injections Training Facials 74

AAAMS

DECEMBER 19, 2024

Whether you’re a physician, nurse, or other medical professional, entering this lucrative field allows you to combine your medical expertise with artistry to help patients look and feel their best. Understanding patient safety protocols and treatment planning. Why Choose a Career in Aesthetic Medicine?

Social Media 52

Social Media Work-Life Balance Training Microneedling 52

New Age Spa Institute

APRIL 18, 2024

In the field of medical aesthetics, lasers are used primarily for hair removal, promoting the destruction of hair follicles and sealing off the vessels that feed hair bulbs. LASER treatments are classified as medical procedures due to their invasive nature and the specific training required to operate these powerful devices.

Legal 40

Legal Hair Removal Safety Esthetician 40

The Dermatology Digest

JANUARY 14, 2024

The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. Zoryve foam was well-tolerated with a favorable safety and tolerability profile. People with seborrheic dermatitis who don’t use topical steroids are 3.5 Zoryve foam; 48.3%

Dermatitis 72

Dermatitis Office Dermatology Safety 72

AAAMS

JULY 17, 2023

Ethics are crucial in the medical field because they help protect patients and medical practices. Ethical doctors prioritize their patients’ best interests to maintain health and safety. Compared to traditional medical practices, aesthetic medicine presents unique ethical challenges.

Ethics 52

Ethics Surgery Legal Safety 52

US Dermatologt Partners

JUNE 1, 2024

These medications have been staples in psoriasis management, particularly in countries like Germany, where they are frequently prescribed for moderate to severe cases. A study involving 245 patients showed significant improvements at 16 weeks, confirming its efficacy and safety in younger populations.6

Therapy 41

Therapy Injections Safety Management 41

NIMA Institute

JUNE 30, 2023

In the fast-paced world of medical esthetics, staying at the forefront of the industry is crucial to success. If you’re looking to expand your skill set and advance your career in medical esthetics, Nima offers comprehensive Botox and filler training that can elevate your expertise to new heights.

Training 52

Training Medical Esthetics Ethics Esthetics 52

The Dermatology Digest

DECEMBER 4, 2024

Restem’s ULSC therapy has shown promising results in early clinical trials, demonstrating safety, tolerability and initial clinically significant improvements, as well as the potential to significantly reduce the need for steroid use in patients.

Treatments 36

Treatments Office Therapy Clinic 36

Aesthetics Advisor

MARCH 30, 2024

HRI researchers discovered that the natural chemical in broccoli, sulforaphane, may improve the performance of tPA and could lead to newer, safer, and more effective medications for acute stroke. “We

Diet 66

Diet Medical Surgery Treatments 66

Aesthetics Advisor

AUGUST 15, 2023

Disclaimer: We in no way endorse the Joe Tippens Cancer Protocol as a cure for cancer, and as always, you should consult your physician before starting any new medications or treatment plans. Click here to buy medical-grade CBD Oil >> (use code RETHN2 for a 20% discount!) What Is Fenbendazole?

Therapy 69

Therapy Medical Safety Diet 69

The Dermatology Digest

MARCH 12, 2024

in patients with HS met its primary endpoint, reinforcing the efficacy and safety profile of ruxolitinib cream 1.5%, demonstrating potential as a novel treatment option for people living with HS,” study author Martina J. Porter, MD, a dermatologist at Beth Israel Deaconess Medical Center in Boston, tells TDD.

Therapy 69

Therapy Safety Dermatology Treatments 69

The Dermatology Digest

JUNE 12, 2024

The product is now available for direct order and delivery to Spanish medical aesthetics healthcare professionals. Evolus, Inc. is rolling out Nuceiva (botulinum toxin type A) across Spain. Nuceiva is licensed in the United States under the brand name Jeuveau. Side effects were similar to others in this class of medicine.

Safety 36

Safety Branding Facials Clinic 36

The Dermatology Digest

MAY 23, 2024

Bimekizumab-bkzx (Bimzelx, UCB) consistently showed sustained improvements in clinical and patient-reported outcomes in patients with moderate to severe hidradenitis suppurativa (HS), according to results from the Phase 3 BE HEARD I and BE HEARD II trials. Bimekizumab-bkzx is an interleukin (IL)-17A and IL-17F inhibitor.

Sustainability 36

Sustainability Safety Clinic Medical 36

Alison Bladh

JANUARY 1, 2025

Medical and Cosmetic Solutions Platelet-Rich Plasma (PRP) Therapy : This treatment involves injecting your plasma into the brow area to stimulate hair growth. Dermatology Clinics. Microblading: Safety and Efficacy in Eyebrow Enhancement. Clinical and Aesthetic Dermatology. Journal of Cosmetic Dermatology.

Treatments 52

Treatments Skincare Routine Hydration Therapy 52